Dawang, Ginalyn S.

HRN: 04-48-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2023
CEFUROXIME 1.5GM (VIAL)
02/28/2023
02/28/2023
IVT
1.5g
On Call To OR
For Stat Primary CS For Uncontrolled Hypertension
Waiting Final Action 
02/28/2023
CEFUROXIME 1.5GM (VIAL)
02/28/2023
03/01/2023
IV
1.5
Q8
LTCS
Waiting Final Action 
02/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/28/2023
03/01/2023
IV
500
TID
LTCS
Waiting Final Action 
03/01/2023
CEFUROXIME 500MG (TAB)
03/01/2023
03/08/2023
PO
500 Mg
BID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: